O	0	14	Identification
O	15	17	of
B-Disease	18	26	Diabetic
I-Disease	27	38	Retinopathy
O	39	42	and
O	43	53	Ungradable
O	54	59	Image
O	60	64	Rate
O	65	69	with
B-Diagnostic_tool	70	79	Ultrawide
I-Diagnostic_tool	80	85	Field
I-Diagnostic_tool	86	93	Imaging
O	94	96	in
O	97	98	a
O	99	107	National
O	108	125	Teleophthalmology
O	126	133	Program
O	133	134	.

O	136	138	To
O	139	146	compare
B-Disease	147	155	diabetic
I-Disease	156	167	retinopathy
O	168	169	(
B-Disease	169	171	DR
O	171	172	)
O	173	187	identification
O	188	191	and
O	192	202	ungradable
O	203	208	image
O	209	214	rates
O	215	222	between
B-Diagnostic_tool	223	235	nonmydriatic
I-Diagnostic_tool	236	245	ultrawide
I-Diagnostic_tool	246	251	field
I-Diagnostic_tool	252	253	(
I-Diagnostic_tool	253	256	UWF
I-Diagnostic_tool	256	257	)
I-Diagnostic_tool	258	265	imaging
O	266	269	and
B-Diagnostic_tool	270	282	nonmydriatic
I-Diagnostic_tool	283	293	multifield
I-Diagnostic_tool	294	300	fundus
I-Diagnostic_tool	301	312	photography
O	313	314	(
B-Diagnostic_tool	314	318	NMFP
O	318	319	)
O	320	322	in
O	323	324	a
O	325	330	large
O	331	341	multistate
O	342	352	population
O	352	353	-
O	353	358	based
B-Disease	359	361	DR
O	362	379	teleophthalmology
O	380	387	program
O	387	388	.

O	389	397	Multiple
O	397	398	-
O	398	402	site
O	402	403	,
O	404	417	nonrandomized
O	417	418	,
O	419	430	consecutive
O	430	431	,
O	432	437	cross
O	437	438	-
O	438	447	sectional
O	447	448	,
O	449	462	retrospective
O	462	463	,
O	464	476	uncontrolled
O	477	484	imaging
O	485	491	device
O	492	502	evaluation
O	502	503	.

O	504	510	Thirty
O	510	511	-
O	511	515	five
O	516	524	thousand
O	525	530	fifty
O	530	531	-
O	531	534	two
B-Anatomy	535	539	eyes
O	540	541	(
O	541	543	17
O	544	547	526
O	548	556	patients
O	556	557	)
O	558	564	imaged
O	565	570	using
B-Diagnostic_tool	571	575	NMFP
O	576	579	and
O	580	582	16
O	583	586	218
B-Anatomy	587	591	eyes
O	592	593	(
O	593	597	8109
O	598	606	patients
O	606	607	)
O	608	614	imaged
O	615	620	using
B-Diagnostic_tool	621	624	UWF
I-Diagnostic_tool	625	632	imaging
O	632	633	.

O	634	637	All
O	638	646	patients
O	647	657	undergoing
B-Diagnostic_tool	658	664	Joslin
I-Diagnostic_tool	665	671	Vision
I-Diagnostic_tool	672	679	Network
I-Diagnostic_tool	680	681	(
I-Diagnostic_tool	681	684	JVN
I-Diagnostic_tool	684	685	)
I-Diagnostic_tool	686	693	imaging
O	694	698	with
O	699	705	either
B-Diagnostic_tool	706	710	NMFP
O	711	713	or
B-Diagnostic_tool	714	717	UWF
I-Diagnostic_tool	718	725	imaging
O	726	730	from
O	731	734	May
O	735	736	1
O	736	737	,
O	738	742	2014
O	742	743	,
O	744	751	through
O	752	758	August
O	759	761	30
O	761	762	,
O	763	767	2015
O	767	768	,
O	769	775	within
O	776	779	the
O	780	786	Indian
O	787	793	Health
O	794	801	Service
O	801	802	-
O	802	805	JVN
O	806	813	program
O	813	814	,
O	815	820	which
O	821	827	serves
B-Characteristic	828	836	American
I-Characteristic	837	843	Indian
O	844	847	and
B-Characteristic	848	854	Alaska
I-Characteristic	855	861	Native
O	862	873	communities
O	874	876	at
O	877	879	97
O	880	885	sites
O	886	892	across
O	893	895	25
O	896	902	states
O	902	903	,
O	904	908	were
O	909	918	evaluated
O	918	919	.

O	920	923	All
B-Diagnostic_tool	924	931	retinal
I-Diagnostic_tool	932	938	images
O	939	943	were
O	944	950	graded
O	951	956	using
O	957	958	a
O	959	971	standardized
O	972	981	validated
O	982	990	protocol
O	991	993	in
O	994	995	a
O	996	1007	centralized
O	1008	1015	reading
O	1016	1022	center
O	1022	1023	.

O	1024	1034	Ungradable
O	1035	1039	rate
O	1040	1043	for
B-Disease	1044	1046	DR
O	1047	1050	and
B-Disease	1051	1059	diabetic
I-Disease	1060	1067	macular
I-Disease	1068	1073	edema
O	1074	1075	(
B-Disease	1075	1078	DME
O	1078	1079	)
O	1079	1080	.

O	1081	1084	The
O	1085	1095	ungradable
O	1096	1100	rate
O	1101	1104	per
O	1105	1112	patient
O	1113	1116	for
B-Disease	1117	1119	DR
O	1120	1123	and
B-Disease	1124	1127	DME
O	1128	1131	was
O	1132	1145	significantly
O	1146	1151	lower
O	1152	1156	with
B-Diagnostic_tool	1157	1160	UWF
I-Diagnostic_tool	1161	1168	imaging
O	1169	1177	compared
O	1178	1182	with
B-Diagnostic_tool	1183	1187	NMFP
O	1188	1189	(
B-Disease	1189	1191	DR
O	1191	1192	,
O	1193	1194	2
O	1194	1195	.
O	1195	1196	8
O	1196	1197	%
O	1198	1200	vs
O	1200	1201	.
O	1202	1204	26
O	1204	1205	.
O	1205	1206	9
O	1206	1207	%
O	1208	1209	[
O	1209	1210	P
O	1212	1213	<
O	1215	1216	0
O	1216	1217	.
O	1217	1221	0001
O	1221	1222	]
O	1222	1223	;
B-Disease	1224	1227	DME
O	1227	1228	,
O	1229	1230	3
O	1230	1231	.
O	1231	1232	8
O	1232	1233	%
O	1234	1236	vs
O	1236	1237	.
O	1238	1240	26
O	1240	1241	.
O	1241	1242	2
O	1242	1243	%
O	1244	1245	[
O	1245	1246	P
O	1248	1249	<
O	1251	1252	0
O	1252	1253	.
O	1253	1257	0001
O	1257	1258	]
O	1258	1259	)
O	1259	1260	.

O	1261	1275	Identification
O	1276	1278	of
B-Anatomy	1279	1283	eyes
O	1284	1288	with
O	1289	1295	either
B-Disease	1296	1298	DR
O	1299	1301	or
B-Disease	1302	1311	referable
I-Disease	1312	1314	DR
O	1315	1316	(
B-Disease	1316	1324	moderate
I-Disease	1325	1341	nonproliferative
I-Disease	1342	1344	DR
O	1345	1347	or
B-Disease	1348	1351	DME
O	1352	1354	or
O	1355	1360	worse
O	1360	1361	)
O	1362	1365	was
O	1366	1375	increased
O	1376	1381	using
B-Diagnostic_tool	1382	1385	UWF
I-Diagnostic_tool	1386	1393	imaging
O	1394	1398	from
O	1399	1401	11
O	1401	1402	.
O	1402	1403	7
O	1403	1404	%
O	1405	1407	to
O	1408	1410	24
O	1410	1411	.
O	1411	1412	2
O	1412	1413	%
O	1414	1415	(
O	1415	1416	P
O	1418	1419	<
O	1421	1422	0
O	1422	1423	.
O	1423	1427	0001
O	1427	1428	)
O	1429	1432	and
O	1433	1437	from
O	1438	1439	6
O	1439	1440	.
O	1440	1441	2
O	1441	1442	%
O	1443	1445	to
O	1446	1448	13
O	1448	1449	.
O	1449	1450	6
O	1450	1451	%
O	1452	1453	(
O	1453	1454	P
O	1456	1457	<
O	1459	1460	0
O	1460	1461	.
O	1461	1465	0001
O	1465	1466	)
O	1466	1467	,
O	1468	1480	respectively
O	1480	1481	.

O	1482	1484	In
B-Anatomy	1485	1489	eyes
O	1490	1494	with
B-Disease	1495	1497	DR
O	1498	1504	imaged
O	1505	1509	with
B-Diagnostic_tool	1510	1513	UWF
I-Diagnostic_tool	1514	1521	imaging
O	1522	1523	(
O	1523	1524	n
O	1525	1526	=
O	1527	1531	3926
B-Anatomy	1532	1536	eyes
O	1537	1539	of
O	1540	1544	2402
O	1545	1553	patients
O	1553	1554	)
O	1554	1555	,
O	1556	1559	the
O	1560	1568	presence
O	1569	1571	of
O	1572	1585	predominantly
B-Symptom	1586	1596	peripheral
I-Symptom	1597	1604	lesions
O	1605	1614	suggested
O	1615	1616	a
O	1617	1621	more
O	1622	1628	severe
O	1629	1634	level
O	1635	1637	of
B-Disease	1638	1640	DR
O	1641	1643	in
O	1644	1645	7
O	1645	1646	.
O	1646	1647	2
O	1647	1648	%
O	1649	1651	of
B-Anatomy	1652	1656	eyes
O	1657	1658	(
O	1658	1659	9
O	1659	1660	.
O	1660	1661	6
O	1661	1662	%
O	1663	1665	of
O	1666	1674	patients
O	1674	1675	)
O	1675	1676	.

O	1677	1679	In
O	1680	1681	a
O	1682	1687	large
O	1687	1688	,
O	1689	1695	widely
O	1696	1707	distributed
B-Disease	1708	1710	DR
O	1711	1717	ocular
O	1718	1728	telehealth
O	1729	1736	program
O	1736	1737	,
O	1738	1740	as
O	1741	1749	compared
O	1750	1754	with
B-Diagnostic_tool	1755	1759	NMFP
O	1759	1760	,
B-Diagnostic_tool	1761	1773	nonmydriatic
I-Diagnostic_tool	1774	1777	UWF
I-Diagnostic_tool	1778	1785	imaging
O	1786	1793	reduced
O	1794	1797	the
O	1798	1804	number
O	1805	1807	of
O	1808	1818	ungradable
B-Anatomy	1819	1823	eyes
O	1824	1826	by
O	1827	1829	81
O	1829	1830	%
O	1830	1831	,
O	1832	1841	increased
O	1842	1845	the
O	1846	1860	identification
O	1861	1863	of
B-Disease	1864	1866	DR
O	1867	1873	nearly
O	1874	1875	2
O	1875	1876	-
O	1876	1880	fold
O	1880	1881	,
O	1882	1885	and
O	1886	1896	identified
B-Symptom	1897	1907	peripheral
I-Symptom	1908	1915	lesions
O	1916	1926	suggesting
O	1927	1931	more
O	1932	1938	severe
B-Disease	1939	1941	DR
O	1942	1944	in
O	1945	1951	almost
O	1952	1954	10
O	1954	1955	%
O	1956	1958	of
O	1959	1967	patients
O	1967	1968	,
O	1969	1973	thus
O	1974	1987	demonstrating
O	1988	1999	significant
O	2000	2008	benefits
O	2009	2011	of
O	2012	2016	this
B-Diagnostic_tool	2017	2024	imaging
I-Diagnostic_tool	2025	2031	method
O	2032	2035	for
O	2036	2041	large
B-Disease	2042	2044	DR
O	2045	2062	teleophthalmology
O	2063	2071	programs
O	2071	2072	.
